SK chemicals is a company leading innovative technology development in the chemical and pharmaceutical sectors since its establishment in 1969. Its main businesses include high-performance eco-friendly chemical materials such as copolyester, engineering plastics, and biopolymers, as well as pharmaceutical manufacturing, sales, and new drug development. The company focuses on building a circular economy through chemical recycling plastic technology and bio-based material development, while strengthening its life science business through vaccine and new drug research.SKchemicalsisacompanyleadinginnovativetechnologydevelopmentinthechemicalandpharmaceuticalsectorssinceitsestablishmentin1969.Itsmainbusinessesincludehigh-performanceeco-friendlychemicalmaterialssuchascopolyester,engineeringplastics,andbiopolymers,aswellaspharmaceuticalmanufacturing,sales,andnewdrugdevelopment.Thecompanyfocusesonbuildingacirculareconomythroughchemicalrecyclingplastictechnologyandbio-basedmaterialdevelopment,whilestrengtheningitslifesciencebusinessthroughvaccineandnewdrugresearch.
Key Products/TechnologiesKeyProducts/Technologies
**Green Chemicals Biz. (Green Chemical Business)**: Copolyester is a group of amorphous resins characterized by excellent transparency, chemical resistance, and processability. Key products include SKYGREEN®, ECOZEN®, CLARO, ECOTRIA, and SKYPET, used in various applications such as cosmetic containers, food containers, baby products, electronic components, and construction materials. Notably, SKYGREEN® PETG is safe, free from Bisphenol derivatives (BPA, etc.) and phthalate-based plasticizers, while ECOZEN, a high-heat PETG, is a bioplastic copolyester blended with biomass-derived materials like corn, capable of withstanding high temperatures. ECOTRIA is an eco-friendly material that maintains high transparency by blending recycled PET. Super Engineering Plastics offer excellent heat resistance, durability, and light resistance, used in automotive, electrical/electronic, industrial, and home appliance applications. DMT (Dimethyl Terephthalate) is a sole domestic supplier used in the synthesis of copolyester, PET, PBT, and other high-quality products like polyester films, fibers, engineering plastics, and adhesives. Development and production of high-performance eco-friendly materials such as biopolyols.**GreenChemicalsBiz.(GreenChemicalBusiness)**:Copolyesterisagroupofamorphousresinscharacterizedbyexcellenttransparency,chemicalresistance,andprocessability.KeyproductsincludeSKYGREEN®,ECOZEN®,CLARO,ECOTRIA,andSKYPET,usedinvariousapplicationssuchascosmeticcontainers,foodcontainers,babyproducts,electroniccomponents,andconstructionmaterials.Notably,SKYGREEN®PETGissafe,freefromBisphenolderivatives(BPA,etc.)andphthalate-basedplasticizers,whileECOZEN,ahigh-heatPETG,isabioplasticcopolyesterblendedwithbiomass-derivedmaterialslikecorn,capableofwithstandinghightemperatures.ECOTRIAisaneco-friendlymaterialthatmaintainshightransparencybyblendingrecycledPET.SuperEngineeringPlasticsofferexcellentheatresistance,durability,andlightresistance,usedinautomotive,electrical/electronic,industrial,andhomeapplianceapplications.DMT(DimethylTerephthalate)isasoledomesticsupplierusedinthesynthesisofcopolyester,PET,PBT,andotherhigh-qualityproductslikepolyesterfilms,fibers,engineeringplastics,andadhesives.Developmentandproductionofhigh-performanceeco-friendlymaterialssuchasbiopolyols.
**Life Science Biz. (Life Science Business)**: Manufacturing and sales of specialized and general pharmaceuticals. Key pharmaceutical products include the ginkgo leaf blood circulation improver 'Ginexin-F', the natural product osteoarthritis treatment 'Joins', the arthritis treatment patch 'Trast', and blood products 'Albumin' and 'Livgamma'. Through its subsidiary SK bioscience, the company produces premium vaccines such as the world's first cell-cultured quadrivalent flu vaccine, the shingles vaccine 'SkyZoster', and the chickenpox vaccine 'SkyVaricella'. It is also pursuing next-generation vaccine development projects, including a pneumococcal vaccine currently in global Phase 3 clinical trials.**LifeScienceBiz.(LifeScienceBusiness)**:Manufacturingandsalesofspecializedandgeneralpharmaceuticals.Keypharmaceuticalproductsincludetheginkgoleafbloodcirculationimprover'Ginexin-F',thenaturalproductosteoarthritistreatment'Joins',thearthritistreatmentpatch'Trast',andbloodproducts'Albumin'and'Livgamma'.ThroughitssubsidiarySKbioscience,thecompanyproducespremiumvaccinessuchastheworld'sfirstcell-culturedquadrivalentfluvaccine,theshinglesvaccine'SkyZoster',andthechickenpoxvaccine'SkyVaricella'.Itisalsopursuingnext-generationvaccinedevelopmentprojects,includingapneumococcalvaccinecurrentlyinglobalPhase3clinicaltrials.
**Electronic Chemicals**: Since 2003, the company has been engaged in high-functional material business for displays and semiconductor materials (Precursor) based on its organic synthesis material capabilities.**ElectronicChemicals**:Since2003,thecompanyhasbeenengagedinhigh-functionalmaterialbusinessfordisplaysandsemiconductormaterials(Precursor)basedonitsorganicsynthesismaterialcapabilities.
Core AdvantagesCoreAdvantages
**Leadership in Eco-friendly Material Technology**: Possession of leading eco-friendly material technologies, including the first domestic development of bottle-grade polyester resin, the world's second commercialization of PETG, and the world's first development of the bioplastic copolyester 'Ecozen'. Commercialization of a circular recycling business based on depolymerization technology, which breaks down waste plastics into molecular units to produce new plastics, expanding its circular economy portfolio.**LeadershipinEco-friendlyMaterialTechnology**:Possessionofleadingeco-friendlymaterialtechnologies,includingthefirstdomesticdevelopmentofbottle-gradepolyesterresin,theworld'ssecondcommercializationofPETG,andtheworld'sfirstdevelopmentofthebioplasticcopolyester'Ecozen'.Commercializationofacircularrecyclingbusinessbasedondepolymerizationtechnology,whichbreaksdownwasteplasticsintomolecularunitstoproducenewplastics,expandingitscirculareconomyportfolio.
**Business Structure Focused on High-Value Specialty Materials**: Reduced reliance on general petrochemical products and repositioned its business portfolio towards high-functional specialty materials with high entry barriers, such as copolyester and super engineering plastics, maintaining stable performance even amidst industry downturns. Copolyester, in particular, has been successfully commercialized by only SK chemicals and Eastman in the world, giving it a near 100% global market share and a dominant competitive edge.**BusinessStructureFocusedonHigh-ValueSpecialtyMaterials**:Reducedrelianceongeneralpetrochemicalproductsandrepositioneditsbusinessportfoliotowardshigh-functionalspecialtymaterialswithhighentrybarriers,suchascopolyesterandsuperengineeringplastics,maintainingstableperformanceevenamidstindustrydownturns.Copolyester,inparticular,hasbeensuccessfullycommercializedbyonlySKchemicalsandEastmanintheworld,givingitanear100%globalmarketshareandadominantcompetitiveedge.
**Innovative Pharmaceutical/Bio Technology**: Possession of innovative new drug development and pharmaceutical technology, including Korea's first new drug 'Sunpla', the first natural product medicine 'Ginexin-F', and the world's first arthritis treatment patch. Secured unique technological capabilities in the vaccine sector, with the world's first quadrivalent cell-cultured flu vaccine and the launch of the shingles vaccine 'SkyZoster'.**InnovativePharmaceutical/BioTechnology**:Possessionofinnovativenewdrugdevelopmentandpharmaceuticaltechnology,includingKorea'sfirstnewdrug'Sunpla',thefirstnaturalproductmedicine'Ginexin-F',andtheworld'sfirstarthritistreatmentpatch.Secureduniquetechnologicalcapabilitiesinthevaccinesector,withtheworld'sfirstquadrivalentcell-culturedfluvaccineandthelaunchoftheshinglesvaccine'SkyZoster'.
**Vertical Integration and Stable Raw Material Supply**: Achieved Korea's first vertical integration in recycling by establishing a joint venture with China's Kelinle for a 'Recycle Feedstock Innovation Center (FIC)', covering everything from waste plastic sourcing to recycled raw material production. This ensures stable raw material supply and cost competitiveness.**VerticalIntegrationandStableRawMaterialSupply**:AchievedKorea'sfirstverticalintegrationinrecyclingbyestablishingajointventurewithChina'sKelinlefora'RecycleFeedstockInnovationCenter(FIC)',coveringeverythingfromwasteplasticsourcingtorecycledrawmaterialproduction.Thisensuresstablerawmaterialsupplyandcostcompetitiveness.
**Global Market Expansion and Enhanced ESG Management**: Successful entry into overseas markets including the US, Europe, Australia, and Brazil, expanding its global business reach. Publishes annual sustainability reports since 2010 and actively pursues ESG management strategies, including expanding the sales ratio of recycled and bio-based products to 90% and achieving net-zero by 2040.**GlobalMarketExpansionandEnhancedESGManagement**:SuccessfulentryintooverseasmarketsincludingtheUS,Europe,Australia,andBrazil,expandingitsglobalbusinessreach.Publishesannualsustainabilityreportssince2010andactivelypursuesESGmanagementstrategies,includingexpandingthesalesratioofrecycledandbio-basedproductsto90%andachievingnet-zeroby2040.
Target IndustrieTargetIndustrie
Cosmetics Industry (containers)CosmeticsIndustry(containers)
Food and Beverage Industry (food containers, beverage bottles, sports tumblers)FoodandBeverageIndustry(foodcontainers,beveragebottles,sportstumblers)
Medical and Pharmaceutical Industry (pharmaceuticals, vaccines, medical device components, transparent materials for quarantine)MedicalandPharmaceuticalIndustry(pharmaceuticals,vaccines,medicaldevicecomponents,transparentmaterialsforquarantine)
Automotive Industry (interior materials, headliners, car mats, components)AutomotiveIndustry(interiormaterials,headliners,carmats,components)
Electrical and Electronic Industry (electronic components, home appliances, high-functional materials for displays, semiconductor materials)ElectricalandElectronicIndustry(electroniccomponents,homeappliances,high-functionalmaterialsfordisplays,semiconductormaterials)
Construction and Industrial Materials (construction materials, industrial products, films, sheets, pipes)ConstructionandIndustrialMaterials(constructionmaterials,industrialproducts,films,sheets,pipes)
Textile Industry (heat transfer films for clothing, synthetic fibers, recycling of blankets and banner waste)TextileIndustry(heattransferfilmsforclothing,syntheticfibers,recyclingofblanketsandbannerwaste)
Adhesive and Coating Industry (steel plates for home appliances, food can coatings, adhesives)AdhesiveandCoatingIndustry(steelplatesforhomeappliances,foodcancoatings,adhesives)
Major MarketsMajorMarkets
Korea, China, Japan, Indonesia, Southeast AsiaKorea,China,Japan,Indonesia,SoutheastAsia
Europe, Italy, BelgiumEurope,Italy,Belgium
United States, North AmericaUnitedStates,NorthAmerica
AustraliaAustralia
Brazil, South America, Argentina, Dominican Republic, Venezuela, Guatemala, BoliviaBrazil,SouthAmerica,Argentina,DominicanRepublic,Venezuela,Guatemala,Bolivia
Certifications/PatentsCertifications/Patents
1,265 domestic patents and 1,830 overseas patents registered (as of December 31, 2024).1,265domesticpatentsand1,830overseaspatentsregistered(asofDecember31,2024).
Acquisition of numerous material-related patents in the Green Chemicals Biz. sector.Acquisitionofnumerousmaterial-relatedpatentsintheGreenChemicalsBiz.sector.
Acquisition of patents for major pharmaceuticals such as Joins and Promac in the Life Science Biz. sector.AcquisitionofpatentsformajorpharmaceuticalssuchasJoinsandPromacintheLifeScienceBiz.sector.
Subsidiary SK bioscience has acquired patents related to influenza vaccines and pneumococcal vaccines.SubsidiarySKbiosciencehasacquiredpatentsrelatedtoinfluenzavaccinesandpneumococcalvaccines.
SKYGREEN® PETG and ECOZEN are certified as safe materials for food contact by the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA).SKYGREEN®PETGandECOZENarecertifiedassafematerialsforfoodcontactbytheU.S.FoodandDrugAdministration(FDA)andtheEuropeanFoodSafetyAuthority(EFSA).
Typhoid vaccine received export product approval from Korea's Ministry of Food and Drug Safety in May 2022 and WHO PQ certification in February 2024.TyphoidvaccinereceivedexportproductapprovalfromKorea'sMinistryofFoodandDrugSafetyinMay2022andWHOPQcertificationinFebruary2024.
Awarded the Carbon Management Sector Honors Award (Raw Materials category) at the 2023 CDP Korea Awards.AwardedtheCarbonManagementSectorHonorsAward(RawMaterialscategory)atthe2023CDPKoreaAwards.
Achieved A- rating in CDP Climate Change and A- rating in Water Security.AchievedA-ratinginCDPClimateChangeandA-ratinginWaterSecurity.
Received MSCI ESG rating of AA for two consecutive years and KCGS A+ rating for three consecutive years.ReceivedMSCIESGratingofAAfortwoconsecutiveyearsandKCGSA+ratingforthreeconsecutiveyears.
Awarded EcoVadis Gold Medal and CDP Climate Change/Water Security Leadership A rating.AwardedEcoVadisGoldMedalandCDPClimateChange/WaterSecurityLeadershipArating.
Received the Minister of Knowledge Economy Award at the 2009 'Korea Technology Awards' (technology name 'SID530').ReceivedtheMinisterofKnowledgeEconomyAwardatthe2009'KoreaTechnologyAwards'(technologyname'SID530').
Kim Han-seok, Head of SK chemicals Research Institute, received the Dongtap Industrial Medal on 'Chemical Industry Day' (for contributions to waste PET recycling technology development and bio-resin development).KimHan-seok,HeadofSKchemicalsResearchInstitute,receivedtheDongtapIndustrialMedalon'ChemicalIndustryDay'(forcontributionstowastePETrecyclingtechnologydevelopmentandbio-resindevelopment).
Introduction
Location
310 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
Information
310 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea